Tag: actos

FDA Confirms Bladder Cancer Risk for Actos

The FDA has concluded that the type-2 diabetes drug Actos (pioglitazone) can increase the risk of bladder cancer. The label will be updated with results from a 13-year study that found a 63% increased risk.